Biléfoi
Natural health product licensed in Canada
- Licence holder
- NuWTR
- NPN or DIN-HM
- 80079109
- Status
- Inactive licence
- Licence date
- 18 July 2017
- Revision date
- 17 May 2018
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Taraxacum officinale Source : Racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 600 milligramme | 150 milligramme | Not calculated |
| Peumus boldus Source : Feuille Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 400 milligramme | 100 milligramme | Not calculated |
| Silybum marianum Source : Graine(s) | 100 milligramme | Not calculated |
| Cnicus benedictus Source : Sommité | 50 milligramme | Not calculated |
| Marrubium vulgare Source : Plante | 50 milligramme | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Traditionally used in Herbal Medicine to help increase bile flow. Traditionally used in Herbal Medicine to help treat digestive disturbances (dyspepsia). Traditionally used in Herbal Medicine to stimulate digestion.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you have an allergy to Asteraceae/ Compositae (daisy) family. Do not use if you are pregnant or breastfeeding.
- Précautions et mises en garde
If you have kidney, liver, or gall bladder diseases or impaired function, and/or intestinal obstruction, consult a health care practitioner prior to use. If symptoms persist or worsen, consult a health care practitioner. If symptoms persist beyond 2 weeks, consult a health care practitioner.
- Effets indésirables connus
Hypersensitivity, such as allergy, has been known to occur; in which case, discontinue use.
Source
Official Health Canada record, licence 80079109
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging